Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Europe midday: Stocks come off highs as investors digest US election aftermath
(Sharecast News) - European markets came off their highs by Wednesday lunchtime but were still trading with impressive gains in the aftermath of the US presidential election, with Donald Trump defeating Kamala Harris to emerge as the clear winner. While votes were still being tallied, Trump looks set to win the majority of votes, taking the swing states of Pennsylvania, North Carolina and Georgia, while being ahead in Michigan, Nevada, and Arizona. The Republican Party is also set to take control of the Senate.
By 1242 CET, Trump had 279 electoral college votes, surpassing the 270 needed to win, ahead of Harris with 223.
The Stoxx 600 was up 1.1% at 515.15, pulling back after surging as much as 1.9% early on, with strong gains in London and Paris met with a more subdued reaction in Frankfurt and Milan, while Spanish stocks fell sharply.
Wall Street futures were pointing to huge gains ahead of the opening bell, with the Dow rising 2.9% the S&P 500 up 2.2% and the Nasdaq gaining 1.6%.
"European markets are in a buoyant mood following a US election that saw Donald Trump sweep to power, casting aside any of the polling doubts that had recently emerged. Despite concerns around the potential implications for trade between the countries, we have seen widespread optimism that Trump's pro-business stance will lift all boats," said Joshua Mahony, chief market analyst at Scope Markets.
In economic news, the Eurozone economy failed to gain ground in October, a closely-watched survey showed on Wednesday, weighed down by weakness in Germany and France. The latest seasonally-adjusted Eurozone composite PMI output index from Hamburg Commercial Bank was revised higher to 50.0, marginally ahead of September's 49.6 and the initial estimate of 49.7.
Producer prices eased in the Eurozone in September, in line with expectations. According to first estimates from Eurostat, industrial producer prices fell 0.6% in both the Eurozone and wider bloc after growing by 0.6% in August.
Meanwhile, activity in the UK construction sector expanded for the eighth straight month in October, though growth eased from a two-year high as uncertainty delayed spending decisions ahead of the Autumn Budget. The S&P Global-CIPS construction PMI fell to 54.3 last month from 57.2 in September, missing the 56 consensus estimate.
Market movers
Companies with heavy exposure to the US market were performing well, such as London-listed equipment rental firm Ashtead, hotels group InterContinental and building materials provider CRH.
Wind-energy firms were falling sharply, including Oersted and Vestas Wind Systems, in the aftermath of the US election results. "Investors who thought Kamala Harris would win might have gone all-in on renewable energy stocks given her pro-green stance, and that trade is now unwinding," said Russ Mould, investment director at AJ Bell.
UK housebuilder Persimmon was a heavy faller after delivering 1,416 homes in the third quarter, slightly down from 1,439 last year. However, the company said it was still on track to hit full-year targets for housing completions this year.
Danish pharma giant Novo Nordisk surged after reporting a 24% increase in third-quarter sales, helped by demand for its diabetes and obesity treatments.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.